Wells Fargo & Company Lowers Mettler-Toledo International (NYSE:MTD) Price Target to $1,350.00

Mettler-Toledo International (NYSE:MTD) had its price objective cut by Wells Fargo & Company from $1,400.00 to $1,350.00 in a report published on Monday,Benzinga reports. They currently have an equal weight rating on the medical instruments supplier’s stock.

MTD has been the subject of a number of other reports. JPMorgan Chase & Co. boosted their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research note on Monday, August 5th. Evercore ISI raised their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Robert W. Baird decreased their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday. Finally, Stifel Nicolaus lifted their price target on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a “buy” rating in a research report on Monday, August 5th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $1,338.75.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,239.13 on Monday. The firm’s 50 day moving average price is $1,388.91 and its two-hundred day moving average price is $1,401.80. The stock has a market cap of $26.15 billion, a price-to-earnings ratio of 33.41, a PEG ratio of 4.16 and a beta of 1.16. Mettler-Toledo International has a twelve month low of $1,039.01 and a twelve month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. The company had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. On average, research analysts forecast that Mettler-Toledo International will post 40.37 EPS for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other news, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now directly owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 1.94% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

Institutional investors have recently modified their holdings of the stock. PineStone Asset Management Inc. raised its position in Mettler-Toledo International by 127.4% in the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock worth $362,855,000 after purchasing an additional 145,453 shares during the last quarter. Capital International Investors lifted its stake in shares of Mettler-Toledo International by 15.1% during the first quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock valued at $1,431,696,000 after acquiring an additional 141,431 shares during the period. International Assets Investment Management LLC boosted its holdings in Mettler-Toledo International by 149,870.0% in the third quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock valued at $134,946,000 after acquiring an additional 89,922 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Mettler-Toledo International by 88.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier’s stock worth $163,290,000 after purchasing an additional 57,509 shares during the period. Finally, TD Asset Management Inc raised its holdings in Mettler-Toledo International by 53.1% during the 1st quarter. TD Asset Management Inc now owns 154,381 shares of the medical instruments supplier’s stock worth $205,526,000 after purchasing an additional 53,561 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.